trial · primary record
TAK-928
IO Resistant Squamous and Nonsquamous NSCLC
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1200 |
| Primary completion | 2029-12-01 |
| Primary endpoint | Squamous NSCLC Part: Confirmed Objective Response Rate (cORR) as Assessed by Blinded Independent Central Review (BICR) per Response Evaluation Criteria in Solid Tumors (RECIST) Version (V)1.1 |
| Registry ID | NCT07217301 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:10.819Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07217301
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.